Xenon Pharmaceuticals shares rose after the company said it received positive data from its study of its investigational treatment for focal onset seizures. Shares rose 46.5% to $61.45.

Xenon Pharmaceuticals released positive topline results from a phase three study of its azetukalner drug for focal onset seizures. The study met its primary endpoint for median percent change in ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Friday's Supreme ...

We're a far cry from the soft, warm amber and yellow of sealed-beam headlights, and while we shouldn't pretend they were perfect, they didn't cause retina sparks either. The main reason manufacturers ...

“The suction power is outstanding for such a compact device.” With this early Black Friday deal at Amazon, you can get the XenonLab Handheld Car Vacuum for just $40, which is nearly 70% off its ...

If you find managing your email annoying, it might be time to switch to another client. Be more productive with one of the top email apps we've tested. I've been testing PC and mobile software for ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

This article covers when attorney-client privilege in New York protects communications. Privilege generally lasts if disclosures are necessary for legal advice, such as to employees or professionals.

Every company likes to believe it puts clients first. But there’s often a wide gap between intention and reality. The reality is, to be client-first is to live and breathe the goals that matter most ...